Alliancebernstein L.P. Axogen, Inc. Transaction History

Alliancebernstein L.P.

$300 Billion
Q3 2025

A detailed history of Alliancebernstein L.P. transactions in Axogen, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 51,220 shares of AXGN stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,220

Previous 47,120 8.7%

Holding current value

$1.21 Million

Previous $511,000 78.67%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$10.77 - $17.84 $44,157 - $73,144	4,100 Added 8.7%	51,220 $913,000
Q2 2025 Aug 14, 2025	SELL	$9.29 - $17.81 $35,023 - $67,143	-3,770 Reduced 7.41%	47,120 $511,000
Q4 2024 Feb 12, 2025	SELL	$12.47 - $17.19 $55,366 - $76,323	-4,440 Reduced 8.02%	50,890 $838,000
Q2 2024 Aug 14, 2024	BUY	$5.67 - $8.06 $42,751 - $60,772	7,540 Added 15.78%	55,330 $400,000
Q4 2023 Feb 14, 2024	SELL	$3.61 - $7.76 $7,328 - $15,752	-2,030 Reduced 4.07%	47,790 $326,000

Q3 2023 Nov 14, 2023	BUY	$4.68 - $9.26 $13,057 - $25,835	2,790 Added 5.93%	49,820 $249,000
Q2 2023 Aug 15, 2023	BUY	$8.5 - $10.38 $10,455 - $12,767	1,230 Added 2.69%	47,030 $429,000
Q2 2022 Aug 15, 2022	SELL	$6.99 - $10.0 $4,194 - $6,000	-600 Reduced 1.29%	45,800 $375,000
Q1 2022 May 13, 2022	BUY	$7.26 - $10.7 $726 - $1,070	100 Added 0.22%	46,400 $368,000
Q3 2021 Nov 10, 2021	SELL	$15.23 - $21.72 $15,230 - $21,720	-1,000 Reduced 2.11%	46,300 $732,000
Q2 2021 Jul 30, 2021	SELL	$17.8 - $23.5 $53,400 - $70,500	-3,000 Reduced 5.96%	47,300 $1.02 Million
Q1 2021 May 06, 2021	SELL	$17.18 - $22.6 $53,258 - $70,060	-3,100 Reduced 5.81%	50,300 $1.02 Million
Q4 2020 Feb 08, 2021	SELL	$11.5 - $17.96 $80,500 - $125,720	-7,000 Reduced 11.59%	53,400 $956,000
Q2 2020 Aug 13, 2020	BUY	$7.35 - $10.81 $72,030 - $105,938	9,800 Added 19.37%	60,400 $558,000
Q1 2020 May 14, 2020	BUY	$8.38 - $17.34 $56,146 - $116,178	6,700 Added 15.26%	50,600 $526,000
Q3 2019 Nov 14, 2019	SELL	$12.09 - $20.46 $105,183 - $178,002	-8,700 Reduced 16.54%	43,900 $548,000
Q2 2019 Aug 14, 2019	BUY	$18.5 - $25.47 $33,300 - $45,846	1,800 Added 3.54%	52,600 $1.04 Million
Q1 2019 May 14, 2019	SELL	$14.62 - $22.13 $23.5 Million - $35.6 Million	-1,607,970 Reduced 96.94%	50,800 $1.07 Million
Q4 2018 Feb 13, 2019	BUY	$17.09 - $38.25 $5.56 Million - $12.4 Million	325,460 Added 24.41%	1,658,770 $33.9 Million
Q3 2018 Nov 08, 2018	BUY	$34.05 - $55.9 $12.3 Million - $20.2 Million	361,090 Added 37.14%	1,333,310 $49.1 Million
Q2 2018 Aug 13, 2018	BUY	$36.15 - $52.5 $32.9 Million - $47.7 Million	909,470 Added 1449.35%	972,220 $48.9 Million
Q1 2018 May 14, 2018	BUY	$24.4 - $40.25 $745,420 - $1.23 Million	30,550 Added 94.88%	62,750 $2.29 Million
Q4 2017 Feb 13, 2018	BUY	$18.5 - $28.6 $246,050 - $380,380	13,300 Added 70.37%	32,200 $911,000
Q3 2017 Nov 13, 2017	BUY	$14.65 - $19.35 $276,885 - $365,715	18,900	18,900 $366,000

Others Institutions Holding AXGN

# of Institutions

186

Shares Held

41.6M

Call Options Held

86.4K

Put Options Held

14.3K

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $1B
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Axogen, Inc. Transaction History